JPWO2019239386A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019239386A5
JPWO2019239386A5 JP2020568956A JP2020568956A JPWO2019239386A5 JP WO2019239386 A5 JPWO2019239386 A5 JP WO2019239386A5 JP 2020568956 A JP2020568956 A JP 2020568956A JP 2020568956 A JP2020568956 A JP 2020568956A JP WO2019239386 A5 JPWO2019239386 A5 JP WO2019239386A5
Authority
JP
Japan
Prior art keywords
acetate
telllipresin
pharmaceutical composition
amount
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020568956A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527084A5 (https=
JP7523775B2 (ja
JP2021527084A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/055004 external-priority patent/WO2019239386A1/en
Publication of JP2021527084A publication Critical patent/JP2021527084A/ja
Publication of JP2021527084A5 publication Critical patent/JP2021527084A5/ja
Publication of JPWO2019239386A5 publication Critical patent/JPWO2019239386A5/ja
Priority to JP2024065219A priority Critical patent/JP2024086898A/ja
Application granted granted Critical
Publication of JP7523775B2 publication Critical patent/JP7523775B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020568956A 2018-06-15 2019-06-14 テルリプレシン組成物及びその使用 Active JP7523775B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024065219A JP2024086898A (ja) 2018-06-15 2024-04-15 テルリプレシン組成物及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862685447P 2018-06-15 2018-06-15
US62/685,447 2018-06-15
PCT/IB2019/055004 WO2019239386A1 (en) 2018-06-15 2019-06-14 Terlipressin compositions and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024065219A Division JP2024086898A (ja) 2018-06-15 2024-04-15 テルリプレシン組成物及びその使用

Publications (4)

Publication Number Publication Date
JP2021527084A JP2021527084A (ja) 2021-10-11
JP2021527084A5 JP2021527084A5 (https=) 2022-06-17
JPWO2019239386A5 true JPWO2019239386A5 (https=) 2022-06-17
JP7523775B2 JP7523775B2 (ja) 2024-07-29

Family

ID=67742882

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020568956A Active JP7523775B2 (ja) 2018-06-15 2019-06-14 テルリプレシン組成物及びその使用
JP2024065219A Pending JP2024086898A (ja) 2018-06-15 2024-04-15 テルリプレシン組成物及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024065219A Pending JP2024086898A (ja) 2018-06-15 2024-04-15 テルリプレシン組成物及びその使用

Country Status (9)

Country Link
US (1) US11931398B2 (https=)
EP (1) EP3806823A1 (https=)
JP (2) JP7523775B2 (https=)
CN (1) CN112969449B (https=)
BR (1) BR112020025380A2 (https=)
CA (1) CA3103215A1 (https=)
MX (1) MX2020013389A (https=)
TW (1) TW202003548A (https=)
WO (1) WO2019239386A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220080023A1 (en) * 2018-12-21 2022-03-17 Arecor Limited Novel composition
KR20220011697A (ko) 2019-05-22 2022-01-28 바이오비에 아이앤씨. 테를리프레신 제형
CN114177147B (zh) * 2021-12-15 2023-05-23 福建省闽东力捷迅药业股份有限公司 一种注射用特利加压素的制备方法以及制得的注射用特利加压素
US20240156895A1 (en) * 2022-10-28 2024-05-16 Mallinckrodt Pharmaceuticals Ireland Limited Compositions for improving kidney function in patients with hepatorenal syndrome

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
CN1244794A (zh) * 1997-11-06 2000-02-16 奥尔班公司 用于药物释放的稳定的干燥药物组合物及其制备方法
RU2415149C2 (ru) * 2006-02-10 2011-03-27 Ферринг Б.В. Пептидные соединения
CN102068685A (zh) * 2010-04-09 2011-05-25 深圳翰宇药业股份有限公司 一种特利加压素制剂及其制备方法
CN102440957B (zh) 2011-12-16 2013-09-25 深圳市健元医药科技有限公司 醋酸特利加压素鼻腔喷雾剂及其制备方法
CN104334117A (zh) 2012-01-26 2015-02-04 恩多沙普公司 用远端和/或近端控制来输送管腔闭塞装置的系统、装置和方法
AR091902A1 (es) * 2012-07-25 2015-03-11 Hanmi Pharm Ind Co Ltd Formulacion liquida de un conjugado de insulina de accion prolongada
CN105592855A (zh) * 2013-04-26 2016-05-18 拉卓拉药物公司 用于治疗肾衰竭的组合物和方法
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
CN106188218B (zh) * 2016-07-14 2018-11-23 江苏诺泰澳赛诺生物制药股份有限公司 一种提高多肽原料药稳定性的方法
GB201721846D0 (en) 2017-12-22 2018-02-07 Arecor Ltd Novel composition
KR20220011697A (ko) 2019-05-22 2022-01-28 바이오비에 아이앤씨. 테를리프레신 제형

Similar Documents

Publication Publication Date Title
JP2021063088A5 (https=)
JP2021527084A5 (https=)
ES2961460T3 (es) Métodos para tratar las infecciones por coronavirus felinas
ES2145115T4 (es) Composiciones inyectables a base de derivados de taxanos.
ES2363600T3 (es) Formulación para medicamentos proteicos sin adición de seroalbumina humana (hsa).
JP2018138578A5 (https=)
CN101198331B (zh) 增溶化制剂
JP2005508981A5 (https=)
RU2005128280A (ru) Композиции иммуноглобулина и способ их получения
JPS6064918A (ja) 消炎剤注射液
JPS6021570B2 (ja) ド−パ類の高濃度製剤の製法
JP2024086898A (ja) テルリプレシン組成物及びその使用
JP2021530554A5 (https=)
JP2007291067A (ja) 医薬組成物
JP4395338B2 (ja) 抗生物質活性を有する薬学的組成物
JP2009521473A5 (https=)
JPWO2019239386A5 (https=)
JP2022028975A5 (https=)
JP2021513521A5 (https=)
JP2005531528A5 (https=)
US4185093A (en) Preparation and method for treatment of hypocalcemia, hypophosphatemia and downer cow syndrome in animals
JP2019502751A5 (https=)
US2550398A (en) Antibiotic compositions
JPH0780760B2 (ja) 安定化されたフエニレフリン系液剤
JPH0717500B2 (ja) １，４−ジヒドロキシ−５，８−ビス〔２−（２−ヒドロキシエチルアミノ）−エチルアミノ〕アントラキノン二塩酸塩の安定な注射用医薬配合物